Effectiveness of risankizumab in the treatment of palmoplantar psoriasis: a 52-week Italian real-life experience

Effectiveness of risankizumab in the treatment of palmoplantar psoriasis: a 52-week Italian real-life experience

Background: Data on the treatment of palmoplantar psoriasis (PP) are scarce, representing a therapeutic challenge. This study aims to assess the efficacy and safety of risankizumab in a population of patients with psoriasis with a palmoplantar involvement, over a 52- week treatment period. Method...

Full description

Bibliographic Details
Main Authors: Giacomo Caldarola, Arianna Zangrilli, Gerardo Palmisano, Mauro Bavetta, Gaia Moretta, Gianluca Pagnanelli, Vincenzo Panasiti, Luca Bianchi, Clara De Simone, Ketty Peris
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2023-01-01
Series:Drugs in Context
Subjects:
efficacy
il-23
psoriasis
real-life
risankizumab
safety
Online Access:https://www.drugsincontext.com/effectiveness-of-risankizumab-in-the-treatment-of-palmoplantar-psoriasis-a-52-week-italian-real-life-experience/

Internet

https://www.drugsincontext.com/effectiveness-of-risankizumab-in-the-treatment-of-palmoplantar-psoriasis-a-52-week-italian-real-life-experience/

Similar Items